BPMC

Blueprint Medicines News

Company Name Stock Ticker Symbol Market Type
Blueprint Medicines Corporation BPMC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
2.50 3.59% 72.22 20:00:00
Open Price Low Price High Price Close Price Prev Close
70.24 70.1335 73.03 72.22 69.72
more quote information »

Recent News

Date Time Source Heading
8/10/202219:32EDGARStatement of Changes in Beneficial Ownership (4)
8/08/202218:49EDGARStatement of Changes in Beneficial Ownership (4)
8/04/202223:33TRMNBlueprint Medicines (BPMC) Receives a Buy from Robert W...
8/04/202216:01PRNUSBlueprint Medicines Announces Inducement Grants Under NASDAQ..
8/03/202208:36TRMNBlueprint Medicines (BPMC) Gets a Hold Rating from SVB..
8/03/202206:27TRMNBlueprint Medicines (BPMC) Gets a Buy Rating from H.C...
8/03/202200:25TRMNAnalysts’ Top Healthcare Picks: Steris (STE), Blueprint..
8/02/202216:59EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/02/202216:19EDGARQuarterly Report (10-q)
8/02/202207:48EDGARCurrent Report Filing (8-k)
8/02/202207:00PRNUSBlueprint Medicines Reports Second Quarter 2022 Results
7/26/202208:00PRNUSBlueprint Medicines to Report Second Quarter 2022 Financial..
7/14/202216:15PRNUSBlueprint Medicines Publishes Inaugural Corporate..
7/07/202216:01PRNUSBlueprint Medicines Announces Inducement Grants Under NASDAQ..
7/07/202212:25TRMNBlueprint Medicines (BPMC) Gets a Buy Rating from JMP..
7/04/202222:05TRMNBlueprint Medicines (BPMC) Gets a Buy Rating from Stifel..
7/03/202222:49TRMNBlueprint Medicines (BPMC) Gets a Buy Rating from Robert W...
7/01/202208:36TRMNBlueprint Medicines (BPMC) Gets a Hold Rating from SVB..
6/30/202216:06EDGARCurrent Report Filing (8-k)
6/30/202207:30GLOBERoyalty Pharma Acquires Royalty Interest in Gavreto From..
6/30/202207:15PRNUSBlueprint Medicines Announces Transformative $1.25 Billion..
6/27/202218:46EDGARStatement of Changes in Beneficial Ownership (4)
6/27/202218:37EDGARInitial Statement of Beneficial Ownership (3)
6/23/202216:26PRNUSBlueprint Medicines Appoints Habib Dable to its Board of..
6/13/202212:15TRMNJMP Securities Sticks to Their Buy Rating for Blueprint..
6/10/202208:26TRMNJefferies Thinks Blueprint Medicines’ Stock is Going to..
6/09/202207:41EDGARCurrent Report Filing (8-k)
6/09/202207:00PRNUSBlueprint Medicines Reports Continued Progress Toward Goal..
6/03/202216:01PRNUSBlueprint Medicines Announces Inducement Grants Under NASDAQ..
5/18/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
5/08/202222:16TRMNStifel Nicolaus Thinks Blueprint Medicines’ Stock is Going..
5/05/202216:01PRNUSBlueprint Medicines Announces Inducement Grants Under NASDAQ..
5/05/202201:05TRMNJMP Securities Thinks Blueprint Medicines’ Stock is Going to..
5/04/202206:26TRMNH.C. Wainwright Thinks Blueprint Medicines’ Stock is Going..
5/03/202207:46EDGARCurrent Report Filing (8-k)
5/03/202207:00PRNUSBlueprint Medicines Reports First Quarter 2022 Results
4/29/202208:34EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/29/202208:31EDGARProxy Statement (definitive) (def 14a)
4/29/202208:01EDGARCurrent Report Filing (8-k)
4/28/202208:45TRMNJMP Securities Thinks Blueprint Medicines’ Stock is Going to..
4/26/202208:00PRNUSBlueprint Medicines to Report First Quarter 2022 Financial..
4/14/202216:02EDGARInitial Statement of Beneficial Ownership (3)
4/11/202206:15TRMNH.C. Wainwright Remains a Buy on Blueprint Medicines (BPMC)
4/11/202200:20TRMNBlueprint Medicines (BPMC) Receives a Buy from JMP..
4/08/202213:57SEEKBlueprint, AstraZeneca ink deal to evaluate combination of..
4/08/202213:00PRNUSBlueprint Medicines Announces BLU-945 Proof-of-Concept Data..
4/06/202216:00PRNUSBlueprint Medicines Announces Inducement Grants Under NASDAQ..
3/31/202216:09EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
3/31/202216:03EDGARAmended Statement of Beneficial Ownership (3/a)
3/25/202210:40SEEKBlueprint Medicines' Ayvakyt gets approval in EU to treat..


Your Recent History
NASDAQ
BPMC
Blueprint ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now